This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • Spotlight on ceritinib in the treatment of ALK+ NS...
Journal

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy.

Read time: 1 mins
Published:5th Jul 2017
Author: Santarpia M, Daffinà MG, D'Aveni A, Marabello G, Liguori A et al.
Availability: Free full text
Ref.:Drug Des Devel Ther. 2017;11:2047-2063.
DOI:10.2147/DDDT.S113500
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest